| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 90810 | Null | 0.0291420747327558 | 0.14806282 |
| NSC 13275 | Null | 0.029142074732756 | 0.28404757 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.029142074732756 | 0.290917 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.029142074732756 | -0.15299356 |
| NSC 164970 | Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- | 0.029142074732756 | 0.21447304 |
| NSC 178248 | Chlorozotocin | 0.029142074732756 | 0.20934028 |
| NSC 248040 | Null | 0.029142074732756 | 0.11477593 |
| NSC 252628 | 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- | 0.029142074732756 | 0.33252843 |
| NSC 602617 | Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- | 0.0321614375606958 | 0.074634956 |
| NSC 642968 | Benzo[g]quinoline-5,10-dione, 5,10-dihydro- 4-[2-(1-piperidinyl)ethenyl]- | 0.0321614375606958 | 0.11514833 |